60 Degrees Pharmaceuticals, Inc.
SXTP
$2.96
$0.103.50%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -535.89% | -1.63% | -151.63% | -25.06% | 116.56% |
| Total Depreciation and Amortization | -23.98% | -32.05% | -42.13% | -56.00% | -16.60% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 111.24% | -72.12% | 113.33% | 54.95% | -253.87% |
| Change in Net Operating Assets | 393.94% | -83.27% | 89.57% | -75.08% | -97.77% |
| Cash from Operations | -40.07% | -2,471.74% | 55.21% | -279.01% | -176.33% |
| Capital Expenditure | -- | 100.00% | -666.67% | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 17,500.00% | 80.56% | -6,539.46% | -124.31% | -196.97% |
| Cash from Investing | 17,472.45% | 96.85% | -6,160.22% | -621.55% | -196.97% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -9.90% | -- | -31.06% | -- | -- |
| Repurchase of Common Stock | -- | 32.78% | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -32.11% | -1,951.28% | 95.42% | -- |
| Cash from Financing | -10.84% | -- | -13.75% | -100.28% | 943.48% |
| Foreign Exchange rate Adjustments | -1,137.50% | -103.69% | -80.65% | 475.00% | 38.46% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 138.25% | -2,056.77% | -21.61% | -11,992.66% | 420.22% |